NCT03233555View on ClinicalTrials.gov

Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer

NACompletedINTERVENTIONAL
Enrollment

535

Participants

Timeline

Start Date

September 3, 2013

Primary Completion Date

January 15, 2020

Study Completion Date

July 31, 2022

Conditions
Stage I Breast CancerStage I Colorectal Cancer AJCC v6 and v7Stage I Prostate CancerStage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage II Colorectal Cancer AJCC v7Stage II Prostate CancerStage IIA Breast CancerStage IIA Colorectal Cancer AJCC v7Stage IIA Prostate CancerStage IIB Breast CancerStage IIB Colorectal Cancer AJCC v7Stage IIB Prostate CancerStage IIC Colorectal Cancer AJCC v7Stage III Colorectal Cancer AJCC v7Stage IIIA Colorectal Cancer AJCC v7Stage IIIB Colorectal Cancer AJCC v7Stage IIIC Colorectal Cancer AJCC v7
Interventions
OTHER

Informational Intervention

Receive brochure

OTHER

Internet-Based Intervention

Have access to EXCELS

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

BEHAVIORAL

Telephone-Based Intervention

Receive quarterly calls

Trial Locations (2)

19111

Fox Chase Cancer Center, Philadelphia

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Rutgers, The State University of New Jersey

OTHER

NCT03233555 - Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer | Biotech Hunter | Biotech Hunter